High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling

• Published in: Cell death & disease 2018-08, Vol.9 (9), p.896-17, Article 896
• Main Authors: Kim, Donghyeok, Choi, Bo-hyun, Ryoo, In-geun, Kwak, Mi-Kyoung
• Format: Article
• Language: English
• Subjects: 13/100; 13/31; 13/89; 38/77; 42/34; 64/60; Aldehyde dehydrogenase; Antibodies; Biochemistry; Biomedical and Life Sciences; Cell Biology; Cell Culture; Chemoresistance; Colon cancer; Colonies; Dehydrogenases; Doxorubicin; Drug resistance; Immunology; L cells; Life Sciences; Ovarian cancer; Retinoic acid; Stem cells; Treatment resistance
• ISSN: 2041-4889; 2041-4889
• DOI: 10.1038/s41419-018-0903-4

Aldehyde dehydrogenase 1A1 (ALDH1A1) is one of cancer stem cell (CSC) markers, and high ALDH1 expression has been related to drug resistance and facilitated tumor growth. In this study, we investigated the potential involvement of nuclear factor erythroid 2-like 2 (NFE2L2/NRF2) in CSC-like properties of ALDH-high ovarian CSCs. Our experimental system, ALDH1A1-high (ALDH-H) subpopulation, was isolated and stabilized using doxorubicin-resistant ovarian cancer A2780 cells. ALDH-H exerted CSC-like properties such as drug resistance, colony/sphere formation, and enhanced tumor growth along with high levels of CSCs markers compared to ALDH1A1-low (ALDH-L). Levels of NRF2 and subsequent target genes substantially increased in ALDH-H cells, and the increase in ALDH1A1 and p62 was associated with NRF2 upregulation. ALDH1A1 -silencing blocked increases in NRF2, drug efflux transporters, and p62, along with CSC markers in ALDH-H cells. The inhibition of p62 , which was elevated in ALDH-H, suppressed NRF2 activation. High NRF2 level was confirmed in the ALDH1-high subpopulation from colon cancer HCT116 cells. The functional implication of NRF2 activation in ovarian CSCs was verified by two experimental approaches. First, CSC-like properties such as high CSC markers, chemoresistance, colony/sphere formation, and tumor growth were significantly inhibited by NRF2 -silencing in ALDH-H cells. Second, all- trans retinoic acid (ATRA) suppressed ALDH1 expression, inhibiting NRF2 activation, which led to the attenuation of CSC-like properties in ALDH-H cells but not in ALDH-L cells. These results provide insight into the molecular basis of the ALDH1A1-mediated development of CSC-like properties such as stress/treatment resistance, and further suggest the therapeutic potential of ATRA in ALDH-high ovarian CSCs.